Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting NCT02710435

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

REDUCER-I: An Observational Study of the Neovasc Reducer™ System — Active Not Recruiting • NCT02710435.

📅 16 Oct 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
NCT ID
NCT02710435
Start
2016-03
Completion
2023-11
ClinicaliQ Trial Snapshot
  • REDUCER-I: An Observational Study of the Neovasc Reducer™ System — Active Not Recruiting • NCT02710435.
  • A study tracking long-term outcomes of a device that reduces pressure in coronary veins to relieve chest pain in patients not helped by standard treatments.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris. Conditions: Angina Pectoris, Angina Pectoris, Stable, Chronic Stable Angina Interventions: Reducer System Lead Sponsor: Shockwave Medical, Inc. Planned Enrollment: 400 participants

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn